Outlook on the Computed Tomography Global Market to 2025 - AI-powered CT Scanners are Promising Cancer Detection Tools Presenting Opportunities
Dublin, July 23, 2021 (GLOBE NEWSWIRE) -- The "Global Computed Tomography Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
An estimated 375 million computed tomography (CT) procedures are carried out globally, increasing annually by 3%-4%. CT has become an indispensable tool in illness diagnosis and management, playing an instrumental role in COVID-19 management. The dynamic CT industry involves many participants introducing technological innovations frequently to match the rapidly evolving needs of clinicians, radiologists, and technologists. CT innovations such as spectral imaging, photon counting (to lower radiation dosage) with new detector materials, wide-area detector, and reconstruction algorithms for multi-detector CT technology are expected to drive the market toward quicker upgrades and equipment refresh.
Most developed economies, such as North America, Western Europe, Japan, and Australia, have a CT penetration of over 80% in their health systems. With CT being used for screening, intervention, and therapy planning and a considerable increase in CT procedures in the last three years, tertiary care hospitals are liaising with secondary care services to handle patient volume. The global CT market is witnessing a gradual shift from low-end CT scanners to mid-high and high-end scanners, primarily due to CT technology innovations in reducing radiation dosage and expanding clinical applications in vascular, oncology, cardiac, and breast cancer imaging.
High-end CT purchases by universities and public hospitals in North America, Western Europe, and Japan are expected to propel the high-end CT segment revenue. The proportion of 16-to-64-slice scanner shipments to diagnostic imaging centers and practices is increasing and anticipated to experience moderate growth during the forecast period (2020-2025).
CT was in the forefront of combat against the COVID-19 pandemic as the majority of countries immediately installed CT for lung screening. Despite new purchases, the capacity of traditional unit shipments per year did not yield its full strength. As such, a pent-up demand for CT to fulfill needs-based requirements is expected during the forecast period.
The COVID-19 pandemic further resulted in the postponement of elective surgeries, which took a toll on patient footfall in radiology and affected CT modality. Procedural volumes declined by 26% in 2020, creating a backlog of procedures. At present, health systems are performing more elective surgeries and addressing the backlog at varying capacities. This continuous surge in demand for procedures, coupled with new CT capacity purchases/replacements, is expected to bolster CT market growth throughout the forecast period, achieving pre-COVID-19 business performance breakeven by 2024 or 2025.
With reimbursement approval from the Current Procedural Terminology (CPT) and European regulations, cardiac imaging has taken a significant stride toward CT usage. Coronary CT angiography is the most commonly used imaging modality to diagnose pulmonary embolism and will remain so during the forecast period.
Key Topics Covered:
1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Strategic Imperative 8
The Impact of the Top Three Strategic Imperatives on the Computed Tomography (CT) Industry
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Opportunity Analysis - Global CT Market
Scope of Analysis
Market Segmentation
Key Competitors for the CT Market
Key Growth Metrics for the CT Market
Growth Drivers for the CT Market
Growth Restraints for the CT Market
Forecast Assumptions
Revenue and Unit Shipment Forecast
Revenue Forecast by Product
Unit Shipment Forecast by Product
Revenue Forecast by Region
Unit Shipment Forecast by Region
Revenue and Unit Shipment Forecast Analysis
Revenue and Unit Shipment Forecast Analysis by Region
Pricing Trends Forecast by Product
Pricing Trends Forecast Analysis by Product
Distribution Channels
Competitive Environment
Revenue Share
Revenue Share Analysis
3. Growth Opportunity Analysis - Low-end CT Segment
Key Growth Metrics for the Low-end CT Segment
Revenue and Unit Shipment Forecast - Low-end CT Segment
Revenue Forecast by Region - Low-end CT Segment
Unit Shipment Forecast by Region - Low-end CT Segment
Revenue and Unit Shipment Forecast Analysis - Low-end CT Segment
4. Growth Opportunity Analysis - Mid-low CT Segment
Key Growth Metrics for the Mid-low CT Segment
Revenue and Unit Shipment Forecast - Mid-low CT Segment
Revenue Forecast by Region - Mid-low CT Segment
Unit Shipment Forecast by Region - Mid-low CT Segment
Revenue and Unit Shipment Forecast Analysis - Mid-low CT Segment
Revenue and Unit Shipment Forecast Analysis by Region - Mid-low CT Segment
5. Growth Opportunity Analysis - Mid-high CT Segment
Key Growth Metrics for the Mid-high CT Segment
Revenue and Unit Shipment Forecast - Mid-high CT Segment
Revenue Forecast by Region - Mid-high CT Segment
Unit Shipment Forecast by Region - Mid-high CT Segment
Revenue and Unit Shipment Forecast Analysis - Mid-high CT Segment
Revenue and Unit Shipment Forecast Analysis by Region - Mid-high CT Segment
6. Growth Opportunity Analysis - High-end CT Segment
Key Growth Metrics for the High-end CT Segment
Revenue and Unit Shipment Forecast - High-end CT Segment
Revenue Forecast by Region - High-end CT Segment
Unit Shipment Forecast by Region - High-end CT Segment
Revenue and Unit Shipment Forecast Analysis - High-end CT Segment
Revenue and Unit Shipment Forecast Analysis by Region - High-end CT Segment
7. Growth Opportunity Analysis - Mobile CT Segment
Key Growth Metrics for the Mobile CT Segment
Revenue and Unit Shipment Forecast - Mobile CT Segment
Revenue Forecast by Region - Mobile CT Segment
Unit Shipment Forecast by Region - Mobile CT Segment
Revenue and Unit Shipment Forecast Analysis - Mobile CT Segment
8. Growth Opportunity Universe
Growth Opportunity 1: Increasing Use of Traditional and Mobile CT in Lung Cancer Screening
Growth Opportunity 2: CT Penetration in Cardiac Centers, Particularly Coronary CT Angiography (CCTA) and Fractional Flow Reserve (FFR) Procedures
Growth Opportunity 3: AI-powered CT Scanners are Promising Cancer Detection Tools
9. Next Steps
Your Next Steps
10. List of Exhibits
Companies Mentioned
AB-CT
Allengers
Canon
GE Healthcare
Hitachi/Fujifilm
Koning Corporation
Philips Healthcare
Samsung Neurologica
Shenzen Anke
Siemens Healthineers
Sinovision
SternMed
United Imaging
WDM
Xoran Technologies
For more information about this report visit https://www.researchandmarkets.com/r/iju9we
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900